Successful heart transplantation for COVID ‐19‐associated post‐infectious fulminant myocarditis

AbstractVarious clinical presentations of the 2019 coronavirus disease (COVID ‐19) have been described, including post‐infectious acute and fulminant myocarditis. Here, we describe the case of a young patient admitted for COVID‐19‐associated post‐infectious fulminant myocarditis. Despite optimal pharmacologic management, haemodynamic status worsened requiring suppor t by veno‐arterial extracorporeal membrane oxygenation. Emergent heart transplantation was required at Day 11 given the absence of cardiac function improvement. The diagnosis of post‐infectious COVID‐19‐associated myocarditis was made from both pathologic examination of the explanted heart a nd positive SARS‐CoV‐2 serology.

Source: ESC Heart Failure - May 2, 2021 Category: Cardiology Authors: Baptiste Gaudriot, Alexandre Mansour, Vincent Thibault, Mathieu Lederlin, Aur élie Cauchois, Bernard Lelong, James T. Ross, Guillaume Leurent, Jean‐Marc Tadié, Matthieu Revest, Jean‐Philippe Verhoye, Erwan Flecher, Nicolas Nesseler Tags: Case Report Source Type: research